Literature DB >> 19341344

Molecular cloning of cDNAs encoding antimicrobial peptide precursors from the skin of the Chinese brown frog, Rana chensinensis.

Dejing Shang1, Fenghui Yu, Junfeng Li, Junjie Zheng, Lifang Zhang, Yang Li.   

Abstract

Skin plays a key role in the daily survival of amphibians. In the present study, six cDNAs encoding amphibian skin antimicrobial peptide precursors from the Chinese brown frog Rana chensinensis, were cloned and identified as preprobrevinin-1CEc, preprobrevinin-1CEb, preprotemporin-1CEa, preprotemporin-1CEb, preprotemporin-1CEc, and preprochensinin-1. Preprotemporin-1CEa, CEb, and CEc are members of the temporin family, which are usually short, hydrophobic, and C-terminally alpha-amidated antimicrobial peptides. Preprobrevinin-1CEa and CEb were identified as members of the brevinin-1 family of antimicrobial peptides, because both peptides contain a "Rana box" that is responsible for forming C-terminal Cys-bridged cyclic heptapeptides. The nucleotide and deduced amino acid sequences of preprochensinin-1 were not similar to any known amphibian skin defensive peptides. Four bioactive peptides were chemically synthesized according to the deduced amino acid sequences of six prepropeptides from R. chensinensis skin, and their antimicrobial, cytotoxic, and haemolytic properties were evaluated. All of the synthesized peptides inhibited the growth of Gram-positive bacteria. Brevinin-1CEa showed a broad spectrum of antimicrobial activity. The novel amphibian skin peptide chensinin-1 was active against Bacillus cereus and Streptococcus lactis at a concentration of 11.6 microM, but did not inhibit the growth of MCF-7 and HeLa cells at 200 microM, and had no haemolytic activity at a concentration of 500 microM. Temporin-1CEa exhibited the greatest ability to inhibit the growth of MCF-7 cells. Its antimicrobial and cytotoxic activities may be due to its high degree of alpha-helical confirmation and amphipathic nature.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19341344     DOI: 10.2108/zsj.26.220

Source DB:  PubMed          Journal:  Zoolog Sci        ISSN: 0289-0003            Impact factor:   0.931


  7 in total

1.  Purification, molecular cloning, and antimicrobial activity of peptides from the skin secretion of the black-spotted frog, Rana nigromaculata.

Authors:  Ang Li; Yong Zhang; Che Wang; Geng Wu; Zhenchun Wang
Journal:  World J Microbiol Biotechnol       Date:  2013-04-30       Impact factor: 3.312

2.  Antimicrobial and anti-inflammatory activities of three chensinin-1 peptides containing mutation of glycine and histidine residues.

Authors:  Weibing Dong; Xiaoman Mao; Yue Guan; Yao Kang; Dejing Shang
Journal:  Sci Rep       Date:  2017-01-05       Impact factor: 4.379

3.  Cell surface binding, uptaking and anticancer activity of L-K6, a lysine/leucine-rich peptide, on human breast cancer MCF-7 cells.

Authors:  Che Wang; Shaodan Dong; Lin Zhang; Ying Zhao; Lili Huang; Xiange Gong; He Wang; Dejing Shang
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

4.  Antibacterial Activity of Rationally Designed Antimicrobial Peptides.

Authors:  Marius B Tincho; Thureyah Morris; Mervin Meyer; Ashley Pretorius
Journal:  Int J Microbiol       Date:  2020-04-08

5.  The Bactericidal Activity of Temporin Analogues Against Methicillin Resistant Staphylococcus aureus.

Authors:  Anna Golda; Paulina Kosikowska-Adamus; Aleksandra Kret; Olena Babyak; Kinga Wójcik; Ewelina Dobosz; Jan Potempa; Adam Lesner; Joanna Koziel
Journal:  Int J Mol Sci       Date:  2019-09-25       Impact factor: 5.923

6.  Rapid cytotoxicity of antimicrobial peptide tempoprin-1CEa in breast cancer cells through membrane destruction and intracellular calcium mechanism.

Authors:  Che Wang; Li-Li Tian; Song Li; Hui-Bing Li; Yang Zhou; He Wang; Qing-Zhu Yang; Li-Jie Ma; De-Jing Shang
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

7.  In Vitro & In Vivo Studies on Identifying and Designing Temporin-1CEh from the Skin Secretion of Rana chensinensis as the Optimised Antibacterial Prototype Drug.

Authors:  Zhuming Ye; Xiaowei Zhou; Xinping Xi; Yu Zai; Mei Zhou; Xiaoling Chen; Chengbang Ma; Tianbao Chen; Lei Wang; Hang Fai Kwok
Journal:  Pharmaceutics       Date:  2022-03-10       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.